This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: COVID-19

May 2020

COVID-19 bulletin 2: clinical practice in the pandemic

BJC Staff

Abstract

This Bulletin features news, commentaries and tips from frontline healthcare professionals treating COVID-19 patients daily and other specialists. Do let us know what you think. COVID-19 and immunology vaccine development expert report on COVID-19 and immunology research COVID-19 and primary care a review of current telemedicine platforms COVID-19 and cardiorenal disease COVID-19 and diabetes Diabetes UK position statement COVID-19 diagnostic glucose/lactate sensor in development COVID-19 and mental health COVID-19 and heart valve disease

| Full text

May 2020

COVID-19 and immunology

Anthony Rees, BJC Staff

Abstract

Professor Anthony Rees writes about the hurdles to overcome in COVID-19 vaccine development At the time of writing there are more than 120 proposed vaccine approaches, seven of which are in clinical trial (Phase 1 or Phase1/2) and 70 or so in preclinical evaluation.1 Of those in clinical studies: two encode vectors where the surface S-protein of COVID-19 is incorporated into a non-replicating chimpanzee adenovirus vector (China and UK) two use a conventional inactivated whole virus (both China) two employ a messenger RNA vector encoding the S-protein (China and USA) one is a DNA vaccine (USA). The time frames for each of these clinical tria

| Full text

May 2020

COVID-19 and primary care

Madeleine Oliver, BJC Staff

Abstract

Telemedicine platforms: Madeleine Oliver reviews their strengths, weaknesses and opportunities In the face of COVID-19, primary care has had to adapt at an incredible pace. With lockdown and social distancing measures in place, face-to-face GP consultations have had to be replaced by new forms of socially distanced care. Recent developments in technologies, such as video calling, mean that there is greater scope in what GPs can achieve remotely. Consultation platforms This crisis and the need it has created for telemedicine platforms has meant that many existing platforms are expanding their capabilities. An example of such a platform is Accu

| Full text

May 2020

COVID-19 and cardiorenal medicine

BJC Staff

Abstract

Notably work conducted by nephrologist Dr Daniel Batlle, (Northwestern University Feinberg School of Medicine, Division of Nephrology and Hypertension, Chicago, Illinois) and co-authors,1 who – having reviewed two recent studies from China – hypothesise it is conceivable that the hypercoagulable state that appears to be a characteristic complication of severe COVID-19 could, in some cases, foster the evolution of acute tubular necrosis to cortical necrosis and, therefore, irreversible kidney failure. The effects of coronavirus on the kidneys are also reviewed in a comprehensive editorial in Kidney International2 which suggests, that altho

| Full text

May 2020

COVID-19 and diabetes

BJC Staff

Abstract

It also provides simple pathways for the management of inpatients with diabetes by admitting teams in secondary care; as clinicians and trainees without diabetes expertise are delivering diabetes care during the COVID-19 pandemic. To date the group, comprising UK‐based specialists in diabetes, pharmacy and psychology, have produced two sets of guidelines, which will be continually revised as new evidence emerges. It is supported by Diabetes UK, the Association of British Clinical Diabetologists, and NHS England. Care home guidance A Diabetes UK position statement for the management of diabetes in care homes during the pandemic has also been

| Full text

May 2020

COVID-19 and mental health

BJC Staff

Abstract

The Academy of Medical Royal Colleges – the coordinating body for the UK and Ireland’s 23 medical Royal Colleges and Faculties – has put together many useful resources on its COVID-19 web pages. A section on self-care resources includes advice on mental health and wellbeing is available at: https://www.aomrc.org.uk/covid-19-mentalwellbeing/ Further mental health assistance is available via the COVID Trauma Response Working Group (https://www.traumagroup.org) which has been formed to help coordinate trauma-informed responses to the COVID outbreak. Composed of psychological trauma specialists, coordinators of the psychosocial response to

| Full text

May 2020

COVID-19 and heart valve disease

BJC Staff

Abstract

Together with other Society presidents, the BHVS president, Dr Benoy Shah, has supported statements for patients published in Heart Valve Voice. See https://heartvalvevoice.com/news/news/statement-heart-valve-voice-and-professional-societies-phase and https://heartvalvevoice.com/news/news/covid-19-and-heart-valve-disease Other articles from COVID-19 Bulletin 2: COVID-19 and immunology vaccine development expert report on COVID-19 and immunology research COVID-19 and primary care a review of current telemedicine platforms COVID-19 and cardiorenal disease COVID-19 and diabetes Diabetes UK position statement COVID-19 diagnostic glucose/lact

| Full text

April 2020

COVID-19 Bulletin 1: clinical practice in the pandemic

Dr Lara Mitchell, Dr Amar Puttanna, BJC Staff

Abstract

COVID-19 Bulletin 1: COVID-19 and care of the elderly COVID-19 and diabetes COVID-19 and heart failure COVID-19 and primary care COVID-19 in cancer patients COVID-19 and cardiovascular disease COVID-19 and respiratory medicine Round up of COVID-19 e-learning, apps and websites

| Full text

April 2020

COVID-19 and care of the elderly

Dr Lara Mitchell, BJC Staff

Abstract

Dr Lara Mitchell gives advice on how to have difficult conversations These are the words of Dr Lara Mitchell (pictured right), a Consultant in Medicine for the Elderly (Queen Elizabeth University Hospital, Glasgow; NHS Greater Glasgow & Clyde). She is also Chair of the British Geriatrics Society Cardiovascular Special Interest Group and a BJC editorial board member. To give healthcare professionals a visual approach to support with difficult conversations around dying with compassion and honesty, Dr Mitchell has produced resource materials with Open Change, an educational design company. A structured way that healthcare professionals can

| Full text

April 2020

COVID-19 and diabetes

Amar Puttanna, BJC Staff

Abstract

Dr Amar Puttanna writes on diabetes and COVID-19 One of the first papers by Wu et al.1 looked at case fatality rates and noted that those with diabetes had a higher rate of 7.3% compared to the overall rate of 2.3%. Further reviews of Chinese patient data from both intensive care and non-intensive care, looking at metabolic disease, noted a diabetes prevalence of 9.7% of patients.2 The authors also noted a two-fold increase in those with diabetes in patients with severe disease (i.e. admitted to intensive care units). Similarly, data from Italy noted that 31.3% of deceased patients with COVID-19 had diabetes.3 It is difficult to conclude anyt

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now